TSI Group Co

TSI Group Co Financial Leverage

The Financial Leverage (Equity Multiplier) of TSI Group Co (603262.SS) as of Oct 20, 2026 is 1.27. In the previous year, Financial Leverage (Equity Multiplier) was 1.33 — a change of -5.20% (lower).

Financial Leverage

1.27

YoY

-5.20%

Last updated:

Financial Leverage (Equity Multiplier) of TSI Group Co is 2024 1.27 . Financial Leverage (Equity Multiplier) of TSI Group Co was 2023 1.33 . It decreases by -5.20% lower compared to the previous year.

The TSI Group Co Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2022
1.54 CNY
Jan 1, 2023
1.33 CNY
Jan 1, 2024
1.27 CNY
The TSI Group Co Financial Leverage history
YEARFinancial LeverageYoY
1.27-5.20%
1.33-13.38%
1.54—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

TSI Group Co Stock analysis

What does TSI Group Co do? TSI Group Co., Ltd. generates revenue through the research, development, and manufacturing of dietary nutritional supplements, primarily selling nutritional raw materials like β-hydroxy β-methyl butyrate (HMB), glucosamine, and chondroitin sulfate, as well as finished products such as tablets and hard capsules. The company markets its branded products under myHMB and GlucosaGreen, targeting both domestic and international consumers through its global distribution channels. Its main customers include health supplement retailers, pharmaceutical companies, and wellness brands that purchase raw materials and finished formulations for their own product lines. TSI Group's product portfolio focuses on high-demand nutritional ingredients, with HMB, glucosamine, and chondroitin sulfate serving as core offerings for sports nutrition and joint health applications. The myHMB brand specifically emphasizes muscle support, while GlucosaGreen targets joint care, aligning with consumer trends in functional nutrition. The company's domestic market presence complements its overseas sales, leveraging its Shanghai headquarters for global operations. The firm's revenue streams are driven by B2B transactions with manufacturers and retailers, as well as direct sales of branded supplements to end consumers in key markets. By maintaining a dual focus on raw material supply and branded consumer products, TSI Group captures value across the nutritional supplement supply chain, from ingredient sourcing to final product delivery. TSI Group Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about TSI Group Co stock

Financial Leverage (Equity Multiplier) of TSI Group Co is 1.27 in 2024.

Financial Leverage (Equity Multiplier) of TSI Group Co changed from 1.33 to 1.27, representing a -5.20% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) TSI Group Co since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s TSI Group Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — TSI Group Co

All Key Metrics — TSI Group Co